Monthly Prescribing Reference

House Dust Mite Sublingual Immunotherapy Tablet Effective in Pediatric Patients

Credit: Getty Images. The study included 1458 children aged 5 to 11 years with a clinical history of HDM-induced allergic rhinitis. ALK’s sublingual allergy immunotherapy tablet was found to be ...
Business Wire

Stallergenes Greer plc: Two New Real-World Evidence Studies Show Long-Term Benefits of Sublingual Allergy Immunotherapy

Oralair is a sublingual allergy immunotherapy tablet with a mix of five grass allergen extracts (Sweet Vernal, Orchard, Perennial Rye, Timothy, and Kentucky Blue Grass Mixed Pollens Allergen Extract) ...
Healio

Sublingual immunotherapy effective for young children with allergic rhinitis

Please provide your email address to receive an email when new articles are posted on . Researchers called this the first study among children aged 1 to 4 years. The treatment group saw improved ...
USA Today

Ditch the Shots & Allergies: Curex’s Telehealth-Enabled Sublingual Therapy

Allergies have plagued over 100 million Americans, presenting a pervasive issue across the nation. Despite the widespread prevalence of allergies, the available treatment options are limited.
Popular Science

Allergy drops could be an at-home alternative to shots

An under-the-tongue treatment is popular in Europe, Canada, and Latin America. Why don’t U.S. allergists offer it? By Esther Landhuis/Undark Published Aug 16, 2023 9:00 PM EDT This article was ...
FiercePharma

Stallergenes Greer gets positive opinion for sublingual allergy immunotherapy

Stallergenes Greer took a big step toward providing its sublingual house dust mite immunotherapy tablet to the European market. The positive outcome of the decentralized registration procedure sets ...
Business Wire

Stallergenes Greer Submits a Marketing Authorisation Application in Europe for Its Sublingual House Dust Mite Allergen Immunotherapy Tablet

LONDON--(BUSINESS WIRE)--Stallergenes Greer, a biopharmaceutical company specialising in treatments for respiratory allergies, announces the submission of a marketing authorisation application for ...
manilatimes

ALK announces successful outcome of phase 2 trial with its tablet for treatment of peanut allergy demonstrating early onset of efficacy

ALK (ALKB:DC / Nasdaq Copenhagen: ALK B) today announced positive topline results from the phase 2 clinical trial (named ‘ALLIANCE’) with its once-daily investigational sublingual immunotherapy (‘SLIT ...
Healio

Black patients with allergic rhinitis see fewer prescriptions for sublingual immunotherapy

Please provide your email address to receive an email when new articles are posted on . Black patients are 46% less likely than white patients to receive sublingual immunotherapy prescriptions for ...
NBC4 Columbus

U.S. FDA Approves Label Expansion for ALK's ODACTRA® (House Dust Mite Allergen Tablet) for Sublingual Use as Immunotherapy to Now Include Children with House Dust Mite Allergy

- ODACTRA is now indicated to treat house dust mite (HDM)-induced allergic rhinitis, with or without conjunctivitis, in children ages 5 through 11 years, in addition to patients 12 through 65 years of ...
BioWorld

Adcom to consider new course for allergy treatment

Although the U.S. is several years behind Europe in how it treats allergies, it may be about to catch up. The FDA’s Allergenic Products Advisory Committee (APAC) is slated this week to look at the ...